发明名称 2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor
摘要 Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein R is R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4 </SUP>and R<SUP>5 </SUP>are H, alkyl or alkoxyalkyl; R<SUP>6 </SUP>is H, alkyl, hydroxyalkyl or -CH<SUB>2</SUB>F; R<SUP>7</SUP>, R<SUP>8 </SUP>and R<SUP>9 </SUP>are H, alkyl, alkoxy, alkylthio, alkoxyalkyl, halo or -CF<SUB>3</SUB>; and Z is optionally substituted aryl, heteroaryl or heteroaryl-alkyl are disclosed. Also disclosed is the use of compounds of formula I in the treatment of central nervous system diseases, in particular Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them.
申请公布号 ZA200508489(B) 申请公布日期 2007.04.25
申请号 ZA20050008489 申请日期 2005.10.19
申请人 SCHERING CORPORATION 发明人 NEUSTADT, BERNARD R.;LIU, HONG;CHACKALAMANNIL, SAMUEL;STAMFORD, ANDREW;HAO, JINSONG;BOYLE, CRAIG D.;SHAH, UNMESH G.
分类号 A61K;A61P;A61P25/16;C07D;C07D487/14 主分类号 A61K
代理机构 代理人
主权项
地址